Empagliflozin and Hepatic Glucose Metabolism

NCT03193684 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Hepatic Glucose Metabolism

Interventions

DRUG: Empagliflozin 25 MG
DRUG: Control

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]